Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S. Asaka M, et al. Among authors: kuwayama h. Helicobacter. 2001 Sep;6(3):254-61. doi: 10.1046/j.1523-5378.2001.00037.x. Helicobacter. 2001. PMID: 11683930 Clinical Trial.
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S; Japan Helicobacter pylori Eradication Study Group. Asaka M, et al. Among authors: kuwayama h. J Gastroenterol. 2003;38(4):339-47. doi: 10.1007/s005350300061. J Gastroenterol. 2003. PMID: 12743773 Clinical Trial.
Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Fujioka T, Arakawa T, Shimoyama T, Yoshikawa T, Itoh M, Asaka M, Ishii H, Kuwayama H, Sato R, Kawai S, Takemoto T, Kobayashi K. Fujioka T, et al. Among authors: kuwayama h. Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:146-52. doi: 10.1046/j.1365-2036.18.s1.20.x. Aliment Pharmacol Ther. 2003. PMID: 12925153 Clinical Trial.
Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients.
Watanabe H, Yamaguchi N, Kuwayama H, Sekine C, Uemura N, Kaise M, Nakamura T, Kubo M, Yoshida S, Haruma K, Inoue M, Shimatani T, Sanuki E, Mieno H, Kawanishi M, Nakazawa S, Tanaka T. Watanabe H, et al. Among authors: kuwayama h. J Int Med Res. 2003 Sep-Oct;31(5):362-9. doi: 10.1177/147323000303100502. J Int Med Res. 2003. PMID: 14587302 Free article. Clinical Trial.
Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
Matsukawa Y, Nishinarita S, Kaneko M, Takei M, Murakami M, Horie T, Kawamura F, Arakawa Y, Kuwayama H, Kurosaka H. Matsukawa Y, et al. Among authors: kuwayama h. Int J Clin Pharmacol Res. 1997;17(4):127-32. Int J Clin Pharmacol Res. 1997. PMID: 9526173 Clinical Trial.
The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan.
Kinoshita Y, Kobayashi T, Kato M, Asahina K, Haruma K, Shimatani T, Inoue S, Kabemura T, Kurosawa S, Kuwayama H, Ashida K, Hirayama M, Kiyama S, Yamamoto M, Suzuki J, Suzuki H, Matsumoto K, Aoshima M. Kinoshita Y, et al. Among authors: kuwayama h. J Gastroenterol. 2006 Jun;41(6):554-61. doi: 10.1007/s00535-006-1804-3. J Gastroenterol. 2006. PMID: 16868803 Clinical Trial.
167 results